healthcare
University of Nebraska Medical Center and ANANDA Scientific announce First Patient Enrolled in FDA-approved clinical trial for Post-Traumatic Stress Disorder (PTSD)
March 16, 2023
The University of Nebraska Medical Center (UNMC) and ANANDA Scientific Inc. today announced that the first patient has been enrolled in an FDA-approved......
Continue Reading >
Innovation in Resistance Management: VECTRONTM T500, a New Vector Control Product, is Prequalified by the World Health Organization (WHO)
March 16, 2023
VECTRONTM T500 is a new IRS product containing TENEBENALTM, the world’s first meta-diamide active ingredient (IRAC Group 30) developed by Mitsui......
Continue Reading >
Novartis launches new $11 billion share buyback
March 14, 2023
Zurich, Mar. 13 (BNA): Novartis has formally launched its new share buyback programmer where it could spend up to 10 billion Swiss francs $10.90......
Continue Reading >
Pfizer buys biotech firm Seagen for $43 billion
March 14, 2023
Paris: US pharmaceutical giant Pfizer announced Monday it had reached a deal to buy biotech firm Seagen, specialising in innovative cancer treatment,......
Continue Reading >
Region’s first Global Robotic MedTech Forum to reveal latest advancements in robotic surgery
March 13, 2023
The US Society of Robotic Surgery and Crescent Healthcare (a Division of the Crescent Group of Companies) host the first Global Robotic MedTech Forum......
Continue Reading >
New Study Evaluates the Use of Masimo PVi® As an Indicator of Fluid Responsiveness to Guide Goal-Directed Fluid Therapy in Adult Neurosurgical Patients
March 7, 2023
Masimo (NASDAQ: MASI) today announced the findings of a prospective study published in the British Journal of Neurosurgery in which Dr. Ankita Dey......
Continue Reading >
Tunis hosts Arab conference on autism, March 1-2
February 28, 2023
(TAP) - A conference on 'Autistic Children: Between Protection and Integration' will be organised on March 1-2 in Tunis by the Social Affairs......
Continue Reading >
Hikma delivers a resilient underlying performance in 2022
February 23, 2023
Hikma Pharmaceuticals PLC (‘Hikma’ or ‘Group’), the multinational pharmaceutical company, today reports its preliminary audited......
Continue Reading >
Ferrer Acquires Worldwide Rights to ASN90, an O-GlcNAcase Inhibitor From Asceneuron, Exclusively to Treat Progressive Supranuclear Palsy (PSP)
February 23, 2023
Spanish pharmaceutical company Ferrer and Swiss clinical stage biotechnology company Asceneuron announce the signing of a licensing agreement in......
Continue Reading >
LevitasBio Launches LeviSelect Suite of Cell Depletion & Enrichment Kits
February 23, 2023
LevitasBio, Inc. (www.levitasbio.com), a premier end-to-end sample processing and cellular analysis provider to the life sciences market, unveils......
Continue Reading >